ABSTRACT
Objective To observe the clinical efficacy of Huoxue Bitong Plaster on lumbar osteoarthritis with blood stasis and cold-dampness blocking collaterals syndrome. Methods Totally 120 patients were randomly divided into treatment group (60 cases) and control group (60 cases). Huoxue Bitong Plaster was applied externally in the treatment group, while Goupigao Plaster was used externally in the control group, once a day, for two weeks. The clinical efficacy was evaluated by observing TCM symptom scores, VAS, Oswestry dability index (ODI), and onset time in both groups before and after treatment. Results The total effective rate was 86.67%(52/60) in treatment group, and 85.00% (51/60) in the control group, with no statistical significance (P>0.05). TCM symptom scores of both groups decreased after treatment (P<0.05). For the effect of relieving back pain and morning stiffness, the treatment group was superior to control group (P<0.05). For the effect of relieving waist heaviness, the control group was better than the treatment group (P<0.05). Besides, VAS and ODI of the treatment group were lower than the control group after treatment (P<0.05). The onset time of lightening back pain, morning stiffness in the treatment group was quicker than control group (P<0.05). For waist heaviness, the onset time in control group was quicker than treatment group (P<0.05). Conclusion Huoxue Bitong Plaster has good efficacy for lumbar osteoarthritis with blood stasis and cold-dampness blocking collaterals syndrome.
ABSTRACT
Objective: To explore the effect of ulinastatin on anti-inflammation and pulmonary function protection with its mechanism for infants at cardiopulmonary bypass surgery. Methods: A total of 38 infants with ventricular septal defect undergoing cardiac operation were randomly divided into 2 groups. Ulinastatin group, the patients received uliastatin 20 000 U/kg,n=20 and Control group, the patients received the same volume of normal saline,n=18. The serum levels of TNF-α, IL-2, IL-l0 were examined at 4 time points: 5 min before skin incision (T1), immediate opening of aorta (T2), 4 hours after operation (T3) and 24 hours after operation (T4). The expressions of CD4+CD45+ T cells and CD4+Foxp3+ T cells were measured at T4. The respiratory index and oxygenation index at 4 time points were compared between 2 groups. Results: Compared with Control group, Ulinastatin group had the lower levels of TNF-α, IL-2 and higher level of IL-l0 at T2, T3, T4; Ulinastatin group also had the higher oxygenation index and lower respiratory index at T2, T3, T4, allP<0.05. Ulinastatin group had less expression of CD4+CD45+ T cells (35.98 ± 3.67)% than Control group (41.94 ± 4.56)% , and more expression of CD4+Foxp3+ T cells (19.65 ± 3.45)% than Control group (6.45 ± 1.47)%,P<0.05-P<0.01. Conclusion: Ulinastatin may improve the differentiation from CD4+CD45+ T cell to Foxp3+CD4+ T cell, down regulating inlfammatory response and protecting pulmonary function for infants at cardiopulmonary bypass surgery.
ABSTRACT
@#目的探讨高水平篮球运动员创伤性前交叉韧带损伤关节镜术后的疗效。方法1991～1998年,国家级篮球运动员前交叉韧带损伤患者9例9膝,其中男4例,女5例;年龄20～27岁,平均25岁;从受伤到手术时间为1～21d,平均11d。均为训练和比赛过程中发生膝关节扭伤,其中合并半月板损伤5例,骨软骨损伤1例。所有患者均行X线、MRI检查,行关节镜下检查并同时实施手术。结果所有患者均在关节镜下行前交叉韧带重建术。术后Lysholm评分优6例、良2例、可1例。全部患者获得随访,随访时间10～18年,平均13年。无感染和再断裂病例。现有5名仍参加全国职业篮球联赛,其他4名从事教练工作。结论篮球运动员膝关节前交叉韧带损伤多为急性撕裂,关节镜下修复具有创伤小、恢复快等优点。远期随访疗效满意。
ABSTRACT
Objective To observe the therapeutic effect of Xuemeian Capsule for intermission of acute leukemia with bone marrow arrest after chemotherapy.Methods A prospective trial was carried out in 136 cases of acute leukemia after chemotherapy. The cases were randomly allocated to two groups.Group A(n=86)was treated with Xuemeian Capsule and routine western medicine and Group B(n=50)with routine western medicine.The changes of hemoglobin,platelet and leukocyte and the hyperplasia of bone marrow were observed.Results The totally effective rate was 93% and 54% in Group A and Group B respectively,the difference being significant(P
ABSTRACT
Objective To assess the therapeutic ef fects of Compound Zaofan Pill (CZP) on aplastic anemia (AA). Methods A prospective randomized control trial was carried out. Thirty_six cases of AA treated with C ZP combined with stanozolol were allocated to Group A and other 30 cases treated with levamisole, prednisone, stanozolol and folacin served as Group B. Hemoglob in content, leukocyte and platelet counts were detected. Results The total e ffective rate was higher in G roup A (86%) than that in Group B ( 53.5% ), the differences bein g significant (P